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CLINICAL AND POPULATION STUDIES
Distinct Body Mass Index Trajectories to 
Young-Adulthood Obesity and Their Different 
Cardiometabolic Consequences
Tom Norris, Liina Mansukoski, Mark S. Gilthorpe , Mark Hamer , Rebecca Hardy , Laura D. Howe, Alun D. Hughes ,  
Leah Li , Emma O’Donnell , Ken K. Ong , George B. Ploubidis , Richard J. Silverwood , Russell M. Viner , William Johnson
OBJECTIVE: Different body mass index (BMI) trajectories that result in obesity may have diverse health consequences, yet this 
heterogeneity is poorly understood. We aimed to identify distinct classes of individuals who share similar BMI trajectories and 
examine associations with cardiometabolic health.
APPROACH AND RESULTS: Using data on 3549 participants in ALSPAC (Avon Longitudinal Study of Parents and Children), a 
growth mixture model was developed to capture heterogeneity in BMI trajectories between 7.5 and 24.5 years. Differences 
between identified classes in height growth curves, body composition trajectories, early-life characteristics, and a panel of 
cardiometabolic health measures at 24.5 years were investigated. The best mixture model had 6 classes. There were 2 
normal-weight classes: normal weight (nonlinear; 35% of sample) and normal weight (linear; 21%). Two classes resulted in 
young-adulthood overweight: normal weight increasing to overweight (18%) and normal weight or overweight (16%). Two 
classes resulted in young-adulthood obesity: normal weight increasing to obesity (6%) and overweight or obesity (4%). The 
normal-weight-increasing-to-overweight class had more unfavorable levels of trunk fat, blood pressure, insulin, HDL (high-
density lipoprotein) cholesterol, left ventricular mass, and E/e′ ratio compared with the always-normal-weight-or-overweight 
class, despite the average BMI trajectories for both classes converging at ≈26 kg/m2 at 24.5 years. Similarly, the normal-
weight-increasing-to-obesity class had a worse cardiometabolic profile than the always-overweight-or-obese class.
CONCLUSIONS: Individuals with high and stable BMI across childhood may have lower cardiometabolic disease risk than 
individuals who do not become overweight or obese until late adolescence.
GRAPHIC ABSTRACT: A graphic abstract is available for this article.
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The number of adults worldwide with obesity increased from ≈100 to 671 million between 1975 and 2016, with an additional 1.3 billion in the overweight range.1 
This epidemic is strongly related to morbidity and mortal-
ity rates, particularly due to diseases affecting the cir-
culatory and endocrine systems.2 Adults with obesity do 
not, however, form a single homogenous group with the 
same health profiles, and a substantial part of the het-
erogeneity is likely explained by different childhood body 
mass index (BMI) trajectories.3
The seminal publication of Abraham et al4 in 1971 
showed that rates of some cardiovascular diseases were 
the highest among individuals who were overweight in 
adulthood but below average weight in childhood. Numer-
ous articles have replicated this type of analysis.5,6 Others 
have investigated how BMI trajectories and growth traits 
differ between subgroups of adults with obesity, which 
are often classified using crude definitions of metabolic 
health.7,8 Fewer studies have, however, used growth 
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individuals who share similar individual BMI trajectories 
and then subsequently investigated how adulthood car-
diometabolic health measures or events differ between 
them.9–11 This is a powerful approach, which does not 
involve arbitrary categorization, conditioning on an out-
come, or imposing linear constraints between growth 
traits and an outcome. The 2018 European Heart Journal 
article by Buscot et al9 used data from 2631 individuals 
in the Cardiovascular Risk in Young Finns Study and is 
arguably the best published example. Even this article, 
however, had serious limitations, including the individual 
BMI trajectories spanning different age ranges for differ-
ent birth cohorts (eg, 6–37 years if born in 1974; 18–49 
years if born in 1962) and multiple categorical outcomes 
being related to classes with few individuals (eg, n=33). 
In addition, no previous study has investigated differ-
ences in height growth and body composition trajectories 
between the classes they identified based on serial BMI 
data. This is fundamentally important to understand and 
interpret not only the classes but also their associations 
with outcomes (eg, one class might have high BMI, yet 
a healthy cardiometabolic profile due to high lean mass).
Using data from the larger and deeply phenotyped 
ALSPAC (Avon Longitudinal Study of Parents and Chil-
dren), we aimed to develop a growth mixture model that 
properly captured heterogeneity in childhood to young-
adulthood BMI trajectories. We further aimed to exten-
sively describe each identified latent class (in terms 
of height growth, body composition trajectories, and 
early-life characteristics) and quantify between-class 
differences in young-adulthood cardiometabolic health 
measures. We hypothesized that there would be 2 dis-
tinct groups of individuals who developed young-adult-
hood obesity and that the more favorable cardiometabolic 
health profile would be observed in the group of individu-
als who were consistently heavy across childhood.
MATERIALS AND METHODS
The ALSPAC data are available to scientists on request via 
the following website, which also provides details and dis-
tributions of the study variables: http://www.bristol.ac.uk/
alspac/researchers/access/. The statistical code for the 
analyses in this article has been placed in GitHub—the open-
access online repository: https://github.com/tomnorris1988/
ALSPAC-BMI-Mixture-model-. Please also see the Major 
Resources Table in the Data Supplement.
Sample
ALSPAC is a prospective birth cohort study.12,13 Pregnant 
women living in the defunct county of Avon in England with 
an expected delivery date between April 1991 and December 
1992 were invited to take part in the study. The total number of 
pregnancies is 15 454, representing 15 589 fetuses of which 
14 901 were alive at 1 year of age. The 688 (ie, 15 589–14 901) 
who did not survive includes miscarriages and fetal loss/death, 
as well as (a low incidence of) neonatal death. Follow-up has 
included parent- and child-completed questionnaires, links to 
routine data, and clinic attendance at 10 sweeps at target ages 
of ≈7, 8, 9, 10, 11, 12, 13, 15, 17, and 24 years. Ethical approval 
for the study was obtained from the ALSPAC Ethics and Law 
Committee and the local research ethics committees (and con-
formed to the Declaration of Helsinki). Informed consent for 
the use of data collected via questionnaires and clinics was 
obtained from participants following the recommendations of 
the ALSPAC Ethics and Law Committee at the time. Consent 
for biological samples has been collected in accordance with 
the Human Tissue Act (2004). The study website contains 
Nonstandard Abbreviations and Acronyms
ALSPAC  Avon Longitudinal Study of Parents and 
Children





• It is unclear how cardiometabolic health profiles dif-
fer between groups of individuals who share simi-
lar childhood to young-adulthood body mass index 
trajectories.
• This study models heterogeneity in childhood to 
young-adulthood body mass index trajectories 
(7.5–24.5 years), using frequent serial data from a 
large birth cohort, and extensively characterize each 
identified latent class with respect to cardiometa-
bolic health.
• We found 6 classes and show how height growth 
curves (7.5 and 17.5 years), body composition tra-
jectories (9.5 and 24.5 years), early-life characteris-
tics, and a comprehensive panel of cardiometabolic 
health measures (24.5 years) are patterned across 
the classes.
• Two classes had average trajectories that led to 
young-adulthood overweight; the class with a 
high but stable body mass index trajectory (16% 
of the sample) had more favorable levels of trunk 
fat, blood pressure, insulin, high-density lipoprotein 
cholesterol, left ventricular mass, and E/e′ ratio (an 
indicator of diastolic function) than the class who 
only transitioned from normal weight to overweight 
in late adolescence (14% of the sample). A similar 
pattern of results was found for 2 classes with aver-
age trajectories that resulted in obesity.
• Building on the limited evidence base, our results 
suggest that individuals with high and stable body 
mass index across childhood may have better car-
diometabolic health than individuals who do not 
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details of all the data that are available through a fully search-
able data dictionary and variable search tool: http://www.bris-
tol.ac.uk/alspac/researchers/our-data/.
Individuals were considered eligible for the analysis if they 
attended the 24-year sweep where cardiometabolic measures 
were collected, had at least 2 BMI serial BMI measurements 
between 7 and 24 years, and had some covariate data. Starting 
with the 4019 individuals who were assessed at the 24-year 
sweep, 294 did not have any data on potential confound-
ers (other than sex and ethnicity) and a further 176 had <2 
serial BMI measurements, after data preparation for mixture 
modeling (Materials in the Data Supplement). The sample for 
the present article, therefore, comprised 3549 individuals, of 
whom >75% had at least 7 BMI measurements. Comparison 
of this sample to the 24-year sweep cohort (n=4019) and the 
ALSPAC cohort of children who were alive at 1 year of age 
(n=14 901) is presented in Table I in the Data Supplement.
Anthropometric and Body Composition Data
Weight and height were measured at all sweeps. Height 
was measured without shoes to the last complete millimeter 
using the Harpenden stadiometer (Holtain, Ltd). Weight was 
 Semiroutine occupations n (%) 191 (7.1)  
 Routine occupations n (%) 171 (6.3)  
Weekly family income, £ 19.1
 ≥400 n (%) 1502 (52.3)  
 300–399 n (%) 633 (22.0)  
 200–299 n (%) 452 (15.8)  
 0–199 n (%) 283 (9.9)  
Family adversity index during pregnancy 1.0
 0 n (%) 1748 (49.7)  
 1 n (%) 940 (26.7)  
 2 n (%) 436 (12.4)  
 ≥3 n (%) 391 (11.1)  
Family adversity index at 0–2 y of age 1.8
 0 n (%) 1125 (32.3)  
 1 n (%) 951 (27.3)  
 2 n (%) 595 (17.1)  
 ≥3 n (%) 814 (23.4)  
Family adversity index at 2–4 y of age 5.9
 0 n (%) 1475 (44.2)  
 1 n (%) 953 (28.5)  
 2 n (%) 493 (14.8)  
 ≥3 n (%) 419 (12.5)  
Breastfeeding duration 6.7
 ≥6 mo n (%) 1509 (45.6)  
 3–5 mo n (%) 583 (17.6)  
 <3 months n (%) 684 (20.7)  
 Never n (%) 535 (16.2)  
BMI indicates body mass index; CSE, certificate of secondary education; and 
IQR, interquartile range.
Table 1. Continued
   %Missing
Table 1. Description of the Study Sample
   %Missing
Sex 0
 Male n (%) 1363 (38.4)  
 Female n (%) 2186 (61.6)  
Ethnicity 3.6
 White n (%) 3287 (96.1)  
 Non-White n (%) 134 (3.9)  
Birth weight, g Mean (SD) 3410 (534) 1.3
Gestational age, wk Mean (SD) 39.5 (1.8) 0
Gestational hypertension 2.2
 No n (%) 2948 (84.9)  
 Yes n (%) 524 (15.1)  
Diabetes in pregnancy 3.2
 No n (%) 3304 (96.1)  
 Yes n (%) 133 (3.9)  
Mother smoked during the first 3 mo of pregnancy 1.4
 No n (%) 2977 (85.1)  
 Yes n (%) 521 (14.9)  
Mother drank alcohol during the first 3 mo of pregnancy 1.9
 No n (%) 2953 (84.8)  
 Yes n (%) 530 (15.2)  
Mother’s age, y Mean (SD) 29.5 (4.5) 0





Mother’s highest qualification 2.5
 Degree n (%) 716 (20.7)  
 A level n (%) 1007 (29.1)  
 O level n (%) 1174 (33.9)  
 Vocational n (%) 242 (7.0)  
 CSE n (%) 321 (9.3)  
Partner’s age, y Mean (SD) 31.8 (5.5) 29.9





Partner’s highest qualification 4.1
 Degree n (%) 914 (26.9)  
 A level n (%) 995 (29.3)  
 O level n (%) 714 (30.0)  
 Vocational n (%) 243 (7.1)  
 CSE n (%) 536 (15.3)  
Partner’s (or mother’s if partner’s missing) occupation 24.0
  Higher managerial, admin-
istrative, and professional 
occupations
n (%) 533 (19.8)  
  Lower managerial, admin-
istrative, and professional 
occupations
n (%) 942 (34.9)  
 Intermediate occupations n (%) 316 (11.7)  
  Small employers and own 
account workers
n (%) 224 (8.3)  
  Lower supervisory and 
technical occupations
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measured to the nearest 0.1 kg using the Tanita Body Fat 
Analyser (model TBF 305). BMI was computed as kilogram per 
square meter. Whole body, trunk, and peripheral fat and lean 
masses were derived from dual-energy x-ray absorptiometry 
scans at target ages 9, 11, 13, 15, 17, and 24 years using a 
Lunar prodigy densitometer (GE Healthcare, Chicago, IL).
Cardiometabolic Health Data
The 24-year sweep included detailed phenotyping and data 
collection using REDCap.14 Resting systolic and diastolic blood 
pressure was measured, after a 2 minute rest, using an Omron 
Healthcare (Kyoto, Japan) M6 upper arm blood pressure moni-
tor. The average of 2 or 3 measurements was used. A fasting 
blood sample was obtained from which cholesterol, HDL (high-
density lipoprotein) cholesterol, LDL (low-density lipoprotein) 
cholesterol, triglycerides, insulin, glucose, and CRP (C-reactive 
protein) were assayed.
Carotid-femoral pulse wave velocity was assessed using 
the oscillometric method (Vicorder; Skidmore Medical, Bristol, 
United Kingdom). Bilateral carotid intima-media thickness 
was measured using established ultrasound machine tech-
niques with a 13.5-MHz linear array broadband transducer 
(CardioHealth; Panasonic, Tokyo, Japan).15 End-diastolic mea-
surements were recorded in the far wall of the right and left 
common carotid arteries (1 cm proximal to the carotid bifurca-
tion) and were averaged for analysis.
Approximately 1 in 2 participants attending the 24-year 
clinic sweep were recruited for detailed cardiac phenotyping. 
An echocardiogram, using a Philips Medical Systems (North 
Andover, MA) EPIQ 7G Ultrasound System equipped with a 
X5-1 transducer, was performed using the American Society 
of Echocardiography protocols.16 Based on previous literature 
and to limit multiple comparisons, 5 clinical parameters were 
computed. Relative wall thickness and left ventricular mass 
indexed to height in m3 are principally indicators of cardiac 
structure. Peak mitral annular velocity in systole measured by 
pulsed Doppler (s′) is principally an indicator of systolic func-
tion. Early/late mitral inflow velocity (E/A ratio) and early mitral 
inflow velocity/mitral annular early diastolic velocity (E/e′ ratio) 
are principally indicators of diastolic function.
Potential Confounder Data
Potential confounding variables of the relationship between 
BMI trajectories and cardiometabolic health measures in adult-
hood included sex, ethnicity, birth weight, gestational age, 
gestational hypertension, diabetes in pregnancy, smoking and 
alcohol consumption during pregnancy, parental age at birth of 
baby, maternal BMI at 12 weeks of gestation, paternal BMI 
at 7-year sweep, breastfeeding duration, parental educational 
qualifications, parental occupation, household income, and a 
family adversity index.
Statistical Analyses
Using Mplus, a growth mixture model (sexes combined) was 
developed to identify distinct groups of individuals who had 
similar BMI trajectories across the 10 sweeps (Figure I in the 
Data Supplement). The data used in, and diagnostics obtained 
from, these mixture models are included in Tables II through VI 
in the Data Supplement and Figure II in the Data Supplement. 
As a sensitivity analysis, we refitted our final growth mixture 
model as a multigroup model, in which the growth parameters 
(ie, intercept, slope, quadratic, and cubic terms) of each trajec-
tory class were allowed to differ by sex. Two figures were pro-
duced: one showing the average fitted trajectories (with 95% 
CIs) between 7.5 and 24.5 years, and the individual observed 
trajectories, for each class and one showing the average tra-
jectories superimposed on the International Obesity Task Force 
ranges (averaged across sex) for obesity, overweight, normal 
weight, and thinness.17
To compare the height growth curves for each latent class, 
we used the Super-Imposition by Translation and Rotation 
model.18 Class-specific models were developed and used 
to plot the average height distance (cm) and velocity (cm/
year) curves between 7.5 and 17.5 years for each class, incor-
porating estimates of age at and magnitude of peak height 
velocity. Multilevel models were developed to describe how 
Table 2. Cardiometabolic Health Data at 24 y of Age
   %Missing
Age, y Mean (SD) 24.5 (0.8) 0
Height, cm Mean (SD) 171.3 (9.2) 1.0
Weight, kg Median (IQR) 70.1 (61.4–81.5) 1.0
BMI, kg/m2 Median (IQR) 23.7 (21.5–27.0) 1.1
Fat mass, kg Median (IQR) 20.5 (15.9–27.7) 3.8
Trunk fat mass, kg Median (IQR) 9.6 (6.9–13.7) 3.8
Peripheral fat mass, kg Median (IQR) 10.1 (7.9–13.3) 3.8
Lean mass, kg Median (IQR) 45.0 (39.6–54.4) 3.8
Trunk lean mass, kg Median (IQR) 21.9 (19.3–25.9) 3.8
Peripheral lean mass, kg Median (IQR) 20.1 (17.2–25.0) 3.8
SBP, mm Hg Mean (SD) 116.0 (11.4) 0.6
DBP, mm Hg Mean (SD) 66.9 (8.0) 0.6
Cholesterol, mmol/L Mean (SD) 4.43 (0.84) 19.1
HDL-C, mmol/L Mean (SD) 1.55 (0.42) 19.1
LDL-C, mmol/L Mean (SD) 2.44 (0.76) 19.1
Triglycerides, mmol/L Median (IQR) 0.84 (0.65–1.15) 19.1
Insulin, uU/mL Median (IQR) 7.46 (5.29–
10.78)
19.1
Glucose, mmol/L Median (IQR) 5.26 (4.95–5.60) 19.1
CRP, mg/L Median (IQR) 0.84 (0.39–2.22) 25.0
PWV, m/s Mean (SD) 6.31 (1.10) 40.7
cIMT, mm Mean (SD) 0.46 (0.05) 49.3
Cardiac structure
 LVMI, g/m3 Mean (SD) 32.5 (7.2) 49.1
 Relative wall thickness Mean (SD) 0.36 (0.06) 48.8
Systolic function
 s′, cm/s Mean (SD) 9.13 (1.24) 45.2
Diastolic function
 E/A ratio Mean (SD) 1.98 (0.57) 44.8
 E/e′ ratio Mean (SD) 5.08 (1.03) 47.3
BMI indicates body mass index; cIMT, carotid intima-media thickness; CRP, 
C-reactive protein; DBP, diastolic blood pressure; HDL-C, high-density lipopro-
tein cholesterol; IQR, interquartile range; LDL-C, low-density lipoprotein cho-
lesterol; LVMI, left ventricular mass indexed to height in m3; PWV, pulse wave 
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body composition, assessed via dual-energy x-ray absorpti-
ometry, changes over age in each class. A single model was 
developed for each of the 6 outcomes: whole-body fat and 
lean masses, trunk fat and lean masses, and peripheral (ie, 
arms+legs) fat and lean masses. Adjustments for height at 
each sweep were made. Using the models, we estimated 
trajectories between 9.5 and 24.5 years, showing how body 
composition in each of the 5 classes differed compared with 
a referent class.
Descriptive statistics for each potential confounder, stratified 
by class, were produced. General linear regression was used to 
estimate differences in each cardiometabolic health measure 
between the classes, with adjustment for all potential confound-
ers. The transformation y=100 log(e)× was used for skewed 
Figure 1. Average fitted trajectories (with 95% CIs) and individual observed trajectories for each class in the final mixture model.
BMI indicates body mass index.
Figure 2. Average fitted trajectories from the final mixture model superimposed on thinness, normal weight, overweight, and 
obesity ranges (averaged across sex).
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outcomes, and the resulting estimates are symmetrical percent-
age differences. These analyses were performed using outcome 
and confounder data that were multiply imputed 100× using 
chained equations and were weighted by the posterior probabili-
ties of most-likely class membership (using importance weights). 
The missing data patterns are shown in Tables VII and VIII in the 
Data Supplement. As sensitivity analyses, the regression mod-
els were rerun 4×. First, stratified by sex; second, not including 
the weights; third, not including any confounder adjustment; and 
finally, using a dataset in which only the potential confounders 
(and not the outcomes) were imputed.
Full details regarding the derivation of echocardiogram 
outcomes, selection of confounding variables, implementation 
of the mixture modeling, Super-Imposition by Translation and 
Rotation analysis, multilevel body composition modeling, and 
multiple imputation have been published in GitHub (reposi-
tory URL: https://github.com/tomnorris1988/ALSPAC-BMI- 
Mixture-model-).
RESULTS
Descriptive statistics of the sample are presented in 
Tables 1 and 2. Briefly, this is a predominantly White Brit-
ish (96.1%) sample of individuals born with a mean birth 
weight of 3.4 kg, to relatively well-educated (≈50% of 
parents educated to A level or beyond) parents from rel-
atively high social classes (>55% fathers in the highest 
2, of 7, social class strata). At age 24 years, the average 
BMI of the sample was 23.7 kg/m2 and the average fat 
mass was 20.5 kg.
Latent BMI Classes
A mixture model with 6 classes and entropy 0.706 pro-
vided the best representation of the serial BMI data and 
the most plausible solution. Figure 1 shows the average 
Figure 3. Height distance and velocity growth curves fitted using Super-Imposition by Translation and Rotation.
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Table 3. Descriptive Statistics for Each Latent Class
Class 5 Class 2 Class 1 Class 3 Class 4 Class 6














 Estimates are percentages or mean (95% CI)
Sex
 Male 45.6 (42.8–48.4) 40.5 (36.9–44.2) 35.3 (31.2–39.4) 29.9 (26.2–33.5) 37.8 (29.4–46.1) 29.5 (23.3–35.8)
 Female 54.4 (51.6–57.2) 59.5 (55.8–63.1) 64.7 (60.6–68.8) 70.1 (66.5–73.8) 62.2 (53.9–70.6) 70.5 (64.2–76.7)
Ethnicity
 White 96.1 (95.0–97.2) 96.2 (94.7–97.7) 95.4 (93.5–97.2) 96.7 (95.2–98.1) 96.6 (93.6–99.7) 94.7 (91.6–97.8)
 Non-White 3.9 (2.8–5.0) 3.8 (2.3–5.3) 4.6 (2.8–6.5) 3.3 (1.9–4.8) 3.4 (0.3–6.4) 5.3 (2.2–8.4)
Birth weight, g 3364 (3334–3395) 3445 (3409–3482) 3450 (3405–3496) 3367 (3321–3413) 3575 (3483–3668) 3444 (3365–3523)
Gestational age, wk 39.4 (39.3–39.6) 39.5 (39.4–39.7) 39.5 (39.4–39.7) 39.4 (39.2–39.5) 39.7 (39.4–40.0) 39.6 (39.4–39.9)
Gestational hypertension
 No 86.8 (84.9–88.8) 86.0 (83.4–88.6) 85.1 (82.0–88.2) 83.0 (80.0–86.1) 70.6 (62.5–78.6) 80.7 (75.1–86.3)
 Yes 13.2 (11.2–15.1) 14.0 (11.4–16.6) 14.9 (11.8–18.0) 17.0 (13.9–20.0) 29.4 (21.4–37.5) 19.3 (13.7–24.9)
Diabetes in pregnancy
 No 96.7 (95.6–97.7) 96.8 (95.5–98.1) 94.8 (92.8–96.8) 95.9 (94.3–97.5) 96.0 (92.5–99.5) 93.0 (89.5–96.6)
 Yes 3.3 (2.3–4.4) 3.2 (1.9–4.5) 5.2 (3.2–7.2) 4.1 (2.5–5.7) 4.0 (0.5–7.5) 7.0 (3.4–10.5)
Mother smoked during the first 3 mo of pregnancy
 No 87.3 (85.4–89.2) 87.9 (85.5–90.2) 83.3 (80.1–86.5) 83.5 (80.5–86.4) 82.2 (75.5–88.8) 79.1 (73.4–84.8)
 Yes 12.7 (10.8–14.6) 12.1 (9.8–14.5) 16.7 (13.5–19.9) 16.5 (13.6–19.5) 17.8 (11.2–24.5) 20.9 (15.2–26.6)
Mother drank alcohol during the first 3 mo of pregnancy
 No 85.4 (83.4–87.5) 84.6 (81.9–87.2) 84.1 (80.8–87.3) 83.1 (80.1–86.1) 79.6 (72.5–86.7) 89.7 (85.5–94.0)
 Yes 14.6 (12.5–16.6) 15.4 (12.8–18.1) 15.9 (12.7–19.2) 16.9 (13.9–19.9) 20.4 (13.3–27.5) 10.3 (6.0–14.5)
Mother’s age, y 29.9 (29.6–30.1) 29.8 (29.5–30.1) 29.6 (29.2–30.0) 29.2 (28.9–29.6) 29.3 (28.5–30.1) 28.5 (27.8–29.1)
Mother’s BMI, kg/m2 22.8 (22.6–23.0) 23.3 (23.0–23.5) 24.5 (24.2–24.9) 24.2 (23.9–24.5) 26.9 (26.1–27.9) 27.6 (26.7–28.4)
Mother’s highest qualification
 Degree 24.5 (22.1–27.0) 22.1 (19.0–25.2) 16.7 (13.4–19.9) 19.8 (16.6–23.0) 14.0 (7.9–20.1) 13.3 (8.6–18.0)
 A level 29.8 (27.2–32.4) 30.8 (27.3–34.2) 33.0 (28.9–37.1) 26.3 (22.7–29.8) 25.8 (18.3–33.4) 22.3 (16.4–28.1)
 O level 32.6 (29.9–35.2) 32.4 (29.0–35.9) 34.9 (30.8–39.0) 33.8 (29.9–37.6) 33.8 (25.5–42.0) 39.2 (32.3–46)
 Vocational 6.0 (4.6–7.3) 7.2 (5.2–9.1) 6.0 (3.9–8.0) 8.5 (6.2–10.8) 9.7 (4.6–14.9) 9.0 (4.9–13.1)
 CSE 7.1 (5.6–8.6) 7.5 (5.7–9.4) 9.5 (6.9–12.1) 11.7 (9.1–14.3) 16.7 (10.1–23.2) 16.3 (11.0–21.5)
Partner’s age, y 32.2 (31.8–32.5) 31.9 (31.5–32.4) 32.0 (31.4–32.5) 31.1 (30.7–31.6) 32.1 (30.9–33.4) 31.1 (30.2–32.1)
Partner’s BMI, kg/m2 24.7 (24.5–24.9) 25.4 (25.1–25.7) 26.0 (25.6–26.4) 25.6 (25.2–25.9) 27.0 (26.2–27.9) 27.6 (26.8–28.5)
Partner’s highest qualification
 Degree 30.1 (27.5–32.8) 30.4 (27.0–33.8) 22.3 (18.7–26.0) 243 (20.8–27.8) 17.8 (11.1–24.5) 16.8 (11.6–22.0)
 A level 28.0 (25.4–30.5) 28.8 (25.4–32.2) 34.7 (30.5–38.9) 28.4 (24.7–32.0) 28.5 (20.6–36.4) 22.0 (16.2–27.8)
 O level 19.6 (17.4–21.9) 20.7 (17.7–23.8) 22.0 (18.4–25.6) 21.5 (18.2–24.9) 21.1 (13.8–28.4) 23.6 (17.6–29.6)
 Vocational 7.8 (6.2–9.3) 6.4 (4.5–8.2) 4.0 (2.3–5.7) 7.7 (5.5–10.0) 10.5 (5.0–16.0) 13.4 (8.4–18.3)
 CSE 14.5 (12.5–16.5) 13.7 (11.2–16.3) 17.0 (13.7–20.3) 18.0 (14.8–21.2) 22.1 (14.7–29.6) 24.2 (18.0–30.3)
Partner’s (or mother’s if partner’s missing) occupation
  Higher managerial, admin-
istrative, and professional 
occupations
20.8 (18.3–23.3) 19.1 (16.0–22.2) 18.2 (14.5–21.8) 16.6 (13.4–19.9) 9.5 (3.8–15.3) 12.8 (7.6–18.0)
  Lower managerial, admin-
istrative, and professional 
occupations
34.4 (31.4–37.4) 37.9 (33.8–41.9) 29.0 (24.5–33.4) 30.8 (26.6–34.9) 32.2 (23–41.5) 27.5 (20.3–34.6)
 Intermediate occupations 11.4 (9.4–13.4) 11.1 (8.5–13.6) 13.2 (9.8–16.6) 10.8 (8.0–13.7) 8.0 (2.3–13.6) 13.6 (7.8–19.3)
  Small employers and own 
account workers
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fitted and individual observed trajectories for each latent 
class, while Figure 2 shows the average fitted trajecto-
ries against the International Obesity Task Force weight 
status ranges. The trajectories for the other class solu-
tions (eg, a model with 2 classes) are shown in Figures 
III through VIII in the Data Supplement. For the chosen 
6 class solution:
• Class 5 comprised 35% of the sample and had a non-
linear average trajectory in the normal-weight range, 
which matches what we would expect due to changes 
in growth velocity during puberty. This class is referred 
to as normal weight (nonlinear).
• Class 2 comprised 21% of the sample and had a near-
linear average trajectory in the normal-weight range. 
This class is referred to as normal weight (linear).
• Class 3 comprised 18% of the sample and had an 
average trajectory that increased from normal weight 
to overweight. This class is referred to as normal 
weight increasing to overweight.
• Class 1 comprised 16% of the sample and had an 
average trajectory that approximated the International 
Obesity Task Force overweight threshold. This class is 
referred to as normal weight or overweight.
• Class 6 comprised 6% of the sample and had an 
average trajectory that increased from normal weight 
to obesity. This class is referred to as normal weight 
increasing to obesity.
• Class 4 comprised 4% of the sample and had an 
average trajectory that approximated the International 
Obesity Task Force obesity threshold. This class is 
referred to as overweight or obesity.
As shown in Table IX in the Data Supplement, there was 
no pattern or relationship between the number of serial mea-
surements a child had and the class they were assigned to. 
  Lower supervisory and tech-
nical occupations
11.4 (9.3–13.5) 10.9 (8.3–13.6) 14.9 (11.4–18.4) 15.5 (12.1–18.8) 13.8 (6.6–21.0) 10.7 (5.5–16.0)
 Semiroutine occupations 6.4 (4.8–8.1) 6.4 (4.4–8.5) 10.7 (7.6–13.7) 8.2 (5.6–10.7) 12.1 (5.4–18.9) 11.3 (5.9–16.7)
 Routine occupations 7.2 (5.4–8.9) 6.5 (4.3–8.7) 4.3 (2.2–6.5) 9.1 (6.4–11.9) 11.2 (4.7–17.7) 13.0 (7.3–18.7)
Weekly family income, £
 ≥400 53.6 (50.5–56.6) 53.9 (49.9–57.8) 47.1 (42.5–51.7) 47.9 (43.7–52.2) 38.4 (29–47.8) 48.2 (40.7–55.6)
 300–399 22.5 (19.9–25.2) 21.3 (18.0–24.5) 26.7 (22.6–30.9) 22.0 (18.3–25.7) 23.3 (14.9–31.8) 17.8 (11.9–23.7)
 200–299 14.1 (11.9–16.3) 16.8 (13.9–19.8) 17.4 (13.9–21.0) 17.4 (14.0–20.8) 27.3 (18.3–36.2) 14.0 (8.5–19.4)
 0–199 9.9 (8.0–11.7) 8.1 (5.9–10.2) 8.8 (6.1–11.4) 12.7 (9.7–15.6) 11.0 (4.9–17.2) 20.1 (13.9–26.2)
Family adversity index during pregnancy
 0 50.8 (48.0–53.6) 52.3 (48.6–56.0) 49.9 (45.6–54.2) 49.4 (45.4–53.4) 44.6 (36.0–53.3) 42.3 (35.5–49.2)
 1 27.2 (24.7–29.8) 26.9 (23.6–30.1) 27.8 (23.9–31.6) 25.6 (22.1–29.1) 27.9 (20.0–35.8) 23.2 (17.4–29.1)
 2 11.6 (9.8–13.4) 11.6 (9.2–14.0) 12.4 (9.6–15.3) 12.7 (10.1–15.4) 12.2 (6.6–17.9) 15.2 (10.3–20.2)
 ≥3 10.4 (8.6–12.1) 9.3 (7.1–11.4) 9.9 (7.4–12.5) 12.2 (9.6–14.8) 15.2 (8.9–21.5) 19.2 (13.7–24.8)
Family adversity index at 0–2 y of age
 0 35.4 (32.6–38.1) 31.8 (28.4–35.3) 28.2 (24.3–32.1) 32.3 (28.5–36.1) 30.1 (22.2–38.1) 29.3 (23.0–35.7)
 1 27.1 (24.5–29.6) 30.2 (26.8–33.6) 29.4 (25.4–33.3) 25.8 (22.3–29.4) 18.3 (11.6–25.1) 26.1 (19.9–32.3)
 2 16.6 (14.5–18.7) 17.5 (14.6–20.3) 16.1 (12.9–19.3) 19.2 (16.0–22.4) 19.8 (12.7–26.9) 15.2 (10.2–20.3)
 ≥3 21.0 (18.7–23.3) 20.5 (17.6–23.5) 26.4 (22.6–30.2) 22.6 (19.3–26.0) 31.8 (23.6–39.9) 29.4 (23.0–35.7)
Family adversity index at 2–4 y of age
 0 45.0 (42.2–47.9) 46.0 (42.3–49.7) 43.8 (39.4–48.1) 42.0 (38.0–46.1) 39.5 (30.8–48.2) 38.7 (31.8–45.6)
 1 30.0 (27.4–32.7) 27.7 (24.3–31.1) 28.5 (24.5–32.4) 29.2 (25.4–32.9) 27.5 (19.5–35.5) 25.6 (19.4–31.7)
 2 14.3 (12.3–16.3) 15.6 (12.8–18.3) 13.3 (10.2–16.3) 16.4 (13.3–19.5) 13.1 (6.9–19.4) 15.6 (10.4–20.9)
 ≥3 10.6 (8.8–12.4) 10.8 (8.4–13.1) 14.5 (11.5–17.5) 12.4 (9.7–15.1) 19.9 (12.7–27.2) 20.1 (14.3–25.8)
Breastfeeding duration
 ≥6 mo 48.7 (45.8–51.6) 48.6 (44.8–52.4) 39.5 (35.2–43.8) 43.5 (39.4–47.6) 31.0 (22.8–39.2) 43.2 (36.0–50.3)
 3–5 mo 16.1 (13.9–18.2) 18.5 (15.6–21.5) 18.9 (15.5–22.4) 19.0 (15.8–22.2) 19.5 (12.4–26.5) 15.8 (10.4–21.1)
 <3 mo 20.9 (18.5–23.3) 18.9 (15.9–21.9) 23.1 (19.4–26.8) 20.3 (16.9–23.6) 35.5 (27.0–44.0) 16.9 (11.4–22.4)
 Never 14.4 (12.3–16.4) 14.0 (11.4–16.6) 18.5 (15.0–22.0) 17.3 (14.2–20.4) 14.0 (7.8–20.2) 24.2 (17.8–30.5)
Results estimated using multiply imputed data and weighted by posterior probabilities of most likely class membership. BMI indicates body mass index; and CSE, 
certificate of secondary education.
Table 3. Continued
Class 5 Class 2 Class 1 Class 3 Class 4 Class 6
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Refitting the growth mixture model as a multigroup model 
did not provide evidence that the growth parameters char-
acterizing each class’ trajectory differed by sex (Table X in 
the Data Supplement; Figure IX in the Data Supplement).
Height and Body Composition Trajectories
Compared with the normal-weight (nonlinear) class, the 5 
other classes were initially taller (on average) but transi-
tioned to being shorter by 17.5 years of age, due to an ear-
lier and lower magnitude of peak height velocity (Figure 3). 
These differences were most pronounced in the normal-
weight-increasing-to-obesity and overweight-or-obesity 
classes. After accounting for differences in height, we 
observed large differences in fat mass trajectories between 
the classes but much smaller differences in lean mass tra-
jectories (Figure 4). The overweight-or-obesity class, for 
example, was estimated to have 15 to 21 kg more total 
body fat than the normal-weight (nonlinear) class between 
9.5 and 24.5 years but only 2 to 6 kg more lean mass. Fig-
ures X and XI in the Data Supplement show similar results 
for trunk and peripheral body composition measures.
Early-Life Characteristics
The percentage of women in the normal-weight-increas-
ing-to-overweight class, and in the normal-weight-
increasing-to-obesity class, was ≈9% higher than in the 
full sample (Table 3). Conversely, the percentage of men 
in the normal-weight (nonlinear) class was ≈7% higher 
than in the full sample. Table 3 also shows a clear, and 
expected, patterning of estimated levels of potential 
confounders across the classes. For example, maternal 
BMI increased across the classes, from 22.8 kg/m2 in 
the normal-weight (nonlinear) class to 27.6 kg/m2 in the 
normal-weight-increasing-to-obesity class, as did rates 
Table 4. Class Differences in Cardiometabolic Health Measures at 24 y of Age Table 4. Continued
Class 5 Class 2 Class 1 Class 3 Class 4 Class 6
Normal weight 
(nonlinear) Normal weight (linear) Normal weight or overweight Normal weight increasing to overweight Overweight or obesity Normal weight increasing to obesity
  95% CI P value  95% CI P value  95% CI P value  95% CI P value  95% CI P value
  B   B   B   B   B   
Height, cm … −0.329 −0.884 to 0.227 0.246 −0.678 −1.293 to −0.063 0.031 −0.751 −1.352 to −0.150 0.014 0.028 −1.155 to 1.211 0.963 −0.303 −1.232 to 0.627 0.523
SBP, mm Hg … 1.102 0.222 to 1.982 0.014 0.777 −0.239 to 1.793 0.134 2.186 1.211 to 3.161 <0.001 5.146 3.178 to 7.114 <0.001 6.604 4.801 to 8.408 <0.001
DBP, mm Hg … 0.936 0.271 to 1.601 0.006 0.903 0.108 to 1.698 0.026 2.043 1.267 to 2.819 <0.001 3.869 2.368 to 5.371 <0.001 7.562 6.031 to 9.092 <0.001
Cholesterol, mmol/L … 0.054 −0.032 to 0.140 0.219 0.063 −0.034 to 0.160 0.205 0.038 −0.055 to 0.131 0.419 0.201 0.028 to 0.373 0.023 0.110 −0.047 to 0.267 0.170
HDL-C, mmol/L … −0.024 −0.063 to 0.015 0.231 −0.013 −0.058 to 0.033 0.583 −0.124 −0.166 to −0.082 <0.001 −0.072 −0.149 to 0.005 0.065 −0.310 −0.380 to −0.240 <0.001
LDL-C, mmol/L … 0.061 −0.017 to 0.140 0.123 0.040 −0.047 to 0.127 0.367 0.109 0.025 to 0.192 0.011 0.172 0.024 to 0.320 0.023 0.262 0.119 to 0.405 <0.001
PWV, m/s … 0.023 −0.099 to 0.145 0.708 0.045 −0.097 to 0.187 0.534 0.054 −0.081 to 0.190 0.432 −0.058 −0.310 to 0.195 0.655 0.294 0.056 to 0.531 0.015
cIMT, mm … −0.001 −0.007 to 0.005 0.789 0.004 −0.003 to 0.011 0.246 0.004 −0.002 to 0.011 0.189 0.008 −0.005 to 0.021 0.240 0.016 0.004 to 0.029 0.012
LVMI, g/m3 … 1.310 0.519 to 2.100 0.001 2.895 1.968 to 3.821 <0.001 3.957 3.069 to 4.846 <0.001 5.151 3.212 to 7.090 <0.001 6.306 3.995 to 8.617 <0.001
Relative wall thickness … 0.005 −0.002 to 0.012 0.191 0.013 0.004 to 0.022 0.007 0.016 0.007 to 0.024 <0.001 0.018 0.002 to 0.035 0.031 0.013 −0.002 to 0.029 0.094
s′, cm/s … 0.016 −0.139 to 0.171 0.839 −0.164 −0.330 to 0.002 0.053 −0.181 −0.354 to −0.008 0.040 −0.267 −0.584 to 0.049 0.098 −0.550 −0.848 to −0.252 <0.001
E/A ratio … −0.020 −0.089 to 0.049 0.565 −0.082 −0.162 to −0.003 0.043 −0.113 −0.185 to −0.041 0.002 −0.097 −0.248 to 0.054 0.206 −0.048 −0.185 to 0.090 0.493
E/e′ ratio … 0.102 −0.022 to 0.226 0.106 −0.014 −0.161 to 0.133 0.855 0.211 0.079 to 0.343 0.002 0.369 0.070 to 0.667 0.016 0.461 0.207 to 0.715 <0.001
  s% s% s% s% s%
Weight … 5.4 4.2 to 6.6 <0.001 12.7 11.2 to 14.3 <0.001 15.2 13.6 to 16.8 <0.001 28.7 24.8 to 32.6 <0.001 42.9 39.9 to 45.8 <0.001
BMI … 5.8 4.7 to 6.9 <0.001 13.5 12.1 to 14.9 <0.001 16.1 14.7 to 17.6 <0.001 28.7 25.1 to 32.2 <0.001 43.2 40.4 to 46.0 <0.001
Fat mass … 17.4 14.7 to 20.2 <0.001 31.5 28.0 to 35.0 <0.001 34.7 31.1 to 38.3 <0.001 60.5 52.5 to 68.5 <0.001 84.2 77.4 to 91.1 <0.001
Trunk fat mass … 20.6 17.1 to 24.1 <0.001 36.4 32.1 to 40.8 <0.001 42.5 38.0 to 46.9 <0.001 70.6 61.0 to 80.2 <0.001 98.9 90.7 to 107.2 <0.001
Peripheral fat mass … 16.1 13.6 to 18.6 <0.001 29.3 26.1 to 32.5 <0.001 29.7 26.4 to 32.9 <0.001 54.1 46.8 to 61.3 <0.001 74.2 68.1 to 80.3 <0.001
Lean mass … 0.8 −0.3 to 1.9 0.171 4.5 3.1 to 5.8 <0.001 6.1 4.9 to 7.4 <0.001 11.8 9.1 to 14.5 <0.001 15.5 10.8 to 20.1 <0.001
Trunk lean mass … 0.0 −1.0 to 1.1 0.934 2.8 1.4 to 4.2 <0.001 4.4 3.2 to 5.7 <0.001 9.8 7.1 to 12.5 <0.001 12.2 7.0 to 17.3 <0.001
Peripheral lean mass … 1.6 0.3 to 2.9 0.018 6.6 5.0 to 8.1 <0.001 8.4 6.9 to 9.9 <0.001 14.9 11.8 to 18.1 <0.001 20.6 16.3 to 25.0 <0.001
Triglycerides … 2.8 −1.2 to 6.8 0.175 6.7 2.0 to 11.4 0.006 9.5 5.0 to 14.0 <0.001 16.2 6.8 to 25.6 0.001 26.5 18.3 to 34.6 <0.001
Insulin … 9.7 4.1 to 15.2 0.001 14−9 7.9 to 21.9 <0.001 24.8 18.4 to 31.2 <0.001 39.0 26.5 to 51.5 <0.001 84.4 72.5 to 96.2 <0.001
Glucose … 0.5 −0.5 to 1.5 0.348 0.9 −0.3 to 2.1 0.147 1.3 0.2 to 2.4 0.022 0.7 −1.1 to 2.6 0.445 4.4 2.4 to 6.5 <0.001
CRP … 10.6 −1.5 to 22.8 0.086 22.4 8.5 to 36.2 0.002 36.6 23.3 to 49.9 <0.001 60.8 35.6 to 86.0 <0.001 110.7 89.5 to 131.8 <0.001
(Continued ) s% estimates are symmetrical percentage differences. Results estimated using confounder-adjusted regression models applied to multiply imputed data and 
weighted by posterior probabilities of most likely class membership. BMI indicates body mass index; cIMT, carotid intima-media thickness; CRP, C-reactive protein; DBP, 
diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LVMI, left ventricular mass indexed to height in m3; 
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of all adverse responses (eg, diabetes in pregnancy, low 
family income, and never breastfeeding).
Cardiometabolic Outcomes
Estimated differences in each cardiometabolic health 
measure between the classes are presented in Tables 4 
and 5. The normal-weight (linear) class had 20.6% (95% 
CI, 17.1–24.1) more trunk fat, and higher blood pres-
sures, left ventricular mass indexed to height in m3, and 
insulin, compared with the normal-weight (nonlinear) ref-
erent class (Table 4). The normal-weight-or-overweight 
and normal-weight-increasing-to-overweight classes 
fared even worse. Despite the average BMI trajectories 
for these classes converged at ≈26 kg/m2 at 24.5 years 
(Figure 2), the normal-weight-increasing-to-overweight 
class had worse levels of blood pressures, HDL cho-
lesterol, left ventricular mass indexed to height in m3, 
E/e′ ratio, trunk fat mass, and insulin compared with 
the normal-weight-or-overweight class (Table 5). The 
overweight-or-obesity and normal-weight-increasing-to-
obesity classes had worse levels of nearly all health mea-
sures compared with the normal-weight (nonlinear) class 
(Table 4). The normal-weight-increasing-to-obesity class, 
for example, had 84.4% (72.5–96.2) higher insulin and 
110.7% (89.5–131.8) higher CRP. The average BMI tra-
jectory for the normal-weight-increasing-to-obesity class 
was considerably higher during early adulthood than that 
for the overweight-or-obesity class (Figure 2), and the 
former had worse levels of some health measures than 
the latter (Table 5).
Table 4. Class Differences in Cardiometabolic Health Measures at 24 y of Age Table 4. Continued
Class 5 Class 2 Class 1 Class 3 Class 4 Class 6
Normal weight 
(nonlinear) Normal weight (linear) Normal weight or overweight Normal weight increasing to overweight Overweight or obesity Normal weight increasing to obesity
  95% CI P value  95% CI P value  95% CI P value  95% CI P value  95% CI P value
  B   B   B   B   B   
Height, cm … −0.329 −0.884 to 0.227 0.246 −0.678 −1.293 to −0.063 0.031 −0.751 −1.352 to −0.150 0.014 0.028 −1.155 to 1.211 0.963 −0.303 −1.232 to 0.627 0.523
SBP, mm Hg … 1.102 0.222 to 1.982 0.014 0.777 −0.239 to 1.793 0.134 2.186 1.211 to 3.161 <0.001 5.146 3.178 to 7.114 <0.001 6.604 4.801 to 8.408 <0.001
DBP, mm Hg … 0.936 0.271 to 1.601 0.006 0.903 0.108 to 1.698 0.026 2.043 1.267 to 2.819 <0.001 3.869 2.368 to 5.371 <0.001 7.562 6.031 to 9.092 <0.001
Cholesterol, mmol/L … 0.054 −0.032 to 0.140 0.219 0.063 −0.034 to 0.160 0.205 0.038 −0.055 to 0.131 0.419 0.201 0.028 to 0.373 0.023 0.110 −0.047 to 0.267 0.170
HDL-C, mmol/L … −0.024 −0.063 to 0.015 0.231 −0.013 −0.058 to 0.033 0.583 −0.124 −0.166 to −0.082 <0.001 −0.072 −0.149 to 0.005 0.065 −0.310 −0.380 to −0.240 <0.001
LDL-C, mmol/L … 0.061 −0.017 to 0.140 0.123 0.040 −0.047 to 0.127 0.367 0.109 0.025 to 0.192 0.011 0.172 0.024 to 0.320 0.023 0.262 0.119 to 0.405 <0.001
PWV, m/s … 0.023 −0.099 to 0.145 0.708 0.045 −0.097 to 0.187 0.534 0.054 −0.081 to 0.190 0.432 −0.058 −0.310 to 0.195 0.655 0.294 0.056 to 0.531 0.015
cIMT, mm … −0.001 −0.007 to 0.005 0.789 0.004 −0.003 to 0.011 0.246 0.004 −0.002 to 0.011 0.189 0.008 −0.005 to 0.021 0.240 0.016 0.004 to 0.029 0.012
LVMI, g/m3 … 1.310 0.519 to 2.100 0.001 2.895 1.968 to 3.821 <0.001 3.957 3.069 to 4.846 <0.001 5.151 3.212 to 7.090 <0.001 6.306 3.995 to 8.617 <0.001
Relative wall thickness … 0.005 −0.002 to 0.012 0.191 0.013 0.004 to 0.022 0.007 0.016 0.007 to 0.024 <0.001 0.018 0.002 to 0.035 0.031 0.013 −0.002 to 0.029 0.094
s′, cm/s … 0.016 −0.139 to 0.171 0.839 −0.164 −0.330 to 0.002 0.053 −0.181 −0.354 to −0.008 0.040 −0.267 −0.584 to 0.049 0.098 −0.550 −0.848 to −0.252 <0.001
E/A ratio … −0.020 −0.089 to 0.049 0.565 −0.082 −0.162 to −0.003 0.043 −0.113 −0.185 to −0.041 0.002 −0.097 −0.248 to 0.054 0.206 −0.048 −0.185 to 0.090 0.493
E/e′ ratio … 0.102 −0.022 to 0.226 0.106 −0.014 −0.161 to 0.133 0.855 0.211 0.079 to 0.343 0.002 0.369 0.070 to 0.667 0.016 0.461 0.207 to 0.715 <0.001
  s% s% s% s% s%
Weight … 5.4 4.2 to 6.6 <0.001 12.7 11.2 to 14.3 <0.001 15.2 13.6 to 16.8 <0.001 28.7 24.8 to 32.6 <0.001 42.9 39.9 to 45.8 <0.001
BMI … 5.8 4.7 to 6.9 <0.001 13.5 12.1 to 14.9 <0.001 16.1 14.7 to 17.6 <0.001 28.7 25.1 to 32.2 <0.001 43.2 40.4 to 46.0 <0.001
Fat mass … 17.4 14.7 to 20.2 <0.001 31.5 28.0 to 35.0 <0.001 34.7 31.1 to 38.3 <0.001 60.5 52.5 to 68.5 <0.001 84.2 77.4 to 91.1 <0.001
Trunk fat mass … 20.6 17.1 to 24.1 <0.001 36.4 32.1 to 40.8 <0.001 42.5 38.0 to 46.9 <0.001 70.6 61.0 to 80.2 <0.001 98.9 90.7 to 107.2 <0.001
Peripheral fat mass … 16.1 13.6 to 18.6 <0.001 29.3 26.1 to 32.5 <0.001 29.7 26.4 to 32.9 <0.001 54.1 46.8 to 61.3 <0.001 74.2 68.1 to 80.3 <0.001
Lean mass … 0.8 −0.3 to 1.9 0.171 4.5 3.1 to 5.8 <0.001 6.1 4.9 to 7.4 <0.001 11.8 9.1 to 14.5 <0.001 15.5 10.8 to 20.1 <0.001
Trunk lean mass … 0.0 −1.0 to 1.1 0.934 2.8 1.4 to 4.2 <0.001 4.4 3.2 to 5.7 <0.001 9.8 7.1 to 12.5 <0.001 12.2 7.0 to 17.3 <0.001
Peripheral lean mass … 1.6 0.3 to 2.9 0.018 6.6 5.0 to 8.1 <0.001 8.4 6.9 to 9.9 <0.001 14.9 11.8 to 18.1 <0.001 20.6 16.3 to 25.0 <0.001
Triglycerides … 2.8 −1.2 to 6.8 0.175 6.7 2.0 to 11.4 0.006 9.5 5.0 to 14.0 <0.001 16.2 6.8 to 25.6 0.001 26.5 18.3 to 34.6 <0.001
Insulin … 9.7 4.1 to 15.2 0.001 14−9 7.9 to 21.9 <0.001 24.8 18.4 to 31.2 <0.001 39.0 26.5 to 51.5 <0.001 84.4 72.5 to 96.2 <0.001
Glucose … 0.5 −0.5 to 1.5 0.348 0.9 −0.3 to 2.1 0.147 1.3 0.2 to 2.4 0.022 0.7 −1.1 to 2.6 0.445 4.4 2.4 to 6.5 <0.001
CRP … 10.6 −1.5 to 22.8 0.086 22.4 8.5 to 36.2 0.002 36.6 23.3 to 49.9 <0.001 60.8 35.6 to 86.0 <0.001 110.7 89.5 to 131.8 <0.001
(Continued ) s% estimates are symmetrical percentage differences. Results estimated using confounder-adjusted regression models applied to multiply imputed data and 
weighted by posterior probabilities of most likely class membership. BMI indicates body mass index; cIMT, carotid intima-media thickness; CRP, C-reactive protein; DBP, 
diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LVMI, left ventricular mass indexed to height in m3; 
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The sensitivity analyses in Tables XI through XV in the 
Data Supplement show similar patterns of results.
DISCUSSION
This article provides the most detailed investigation in the 
literature of latent-childhood to young-adulthood BMI tra-
jectory classes and their cardiometabolic consequences. 
We found and describe 6 classes in the ALSPAC sample: 
2 classes had BMI trajectories that resulted in young-
adulthood normal weight, 2 classes had BMI trajecto-
ries that resulted in young-adulthood overweight, and 
2 classes had BMI trajectories that resulted in young-
adulthood obesity. The classes demonstrated remarkable 
differences in fat mass, but not lean mass, trajectories. 
Average levels of most cardiometabolic health measures, 
including echocardiogram measures of heart struc-
ture and function, were worse in the classes that led to 
overweight or obesity. Our key finding, however, is that 
classes with average BMI trajectories that were high and 
stable had better cardiometabolic health profiles than 
classes with average BMI trajectories that demonstrated 
rapid gain and transitioned in late adolescence from nor-
mal weight to overweight or obesity.
A recent systematic review found 14 studies that 
had used mixture modeling to investigate BMI trajec-
tories from birth onward,19 and additional articles have 
considered different age windows in childhood or adult-
hood.20–22 In our literature search, only 3 publications 
had applied growth mixture modeling to capture hetero-
geneity in age-related BMI trajectories spanning child-
hood into adulthood and subsequently related the latent 
Table 5. Class Differences in Cardiometabolic Health Measures at 24 y of Age
Class 1 Class 3 Class 4 Class 6
Normal weight 
or overweight Normal weight increasing to overweight
Overweight 
or obesity Normal weight increasing to obesity
  95% CI P value   95% CI P value
  B    B   
Height, cm … −0.073 −0.759 to 0.613 0.834 … −0.331 −1.686 to 1.024 0.632
SBP, mm Hg … 1.409 0.258 to 2.560 0.016 … 1.458 −0.971 to 3.887 0.239
DBP, mm Hg … 1.140 0.209 to 2.071 0.016 … 3.692 1.709 to 5.676 <0.001
Cholesterol, mmol/L … −0.025 −0.130 to 0.081 0.648 … −0.091 −0.304 to 0.123 0.404
HDL-C, mmol/L … −0.111 −0.162 to −0.061 <0.001 … −0.238 −0.332 to −0.143 <0.001
LDL-C, mmol/L … 0.069 −0.027 to 0.165 0.161 … 0.090 −0.098 to 0.278 0.348
PWV, m/s … 0.009 −0.142 to 0.161 0.905 … 0.351 0.021 to 0.681 0.037
cIMT, mm … 0.000 −0.007 to 0.008 0.916 … 0.008 −0.008 to 0.025 0.321
LVMI, g/m3 … 1.063 0.034 to 2.092 0.043 … 1.155 −1.505 to 3.815 0.394
Relative wall thickness … 0.003 −0.008 to 0.013 0.604 … −0.005 −0.027 to 0.017 0.656
s′, cm/s … −0.017 −0.217 to 0.182 0.865 … −0.283 −0.663 to 0.097 0.144
E/A ratio … −0.031 −0.118 to 0.056 0.483 … 0.049 −0.133 to 0.231 0.596
E/e′ ratio … 0.225 0.073 to 0.376 0.004 … 0.092 −0.275 to 0.459 0.621
  s%  s%
Weight … 2.5 0.6 to 4.4 0.009 … 14.2 9.5 to 18.8 <0.001
BMI … 2.7 0.9 to 4.4 0.003 … 14.5 10.3 to 18.8 <0.001
Fat mass … 3.2 −1.0 to 7.5 0.132 … 23.7 14.1 to 33.3 <0.001
Trunk fat mass … 6.0 0.9 to 11.2 0.022 … 28.3 16.8 to 39.8 <0.001
Peripheral fat mass … 0.4 −3.5 to 4.2 0.853 … 20.1 11.4 to 28.8 <0.001
Lean mass … 1.7 0.3 to 3.0 0.019 … 3.7 −0.9 to 8.2 0.113
Trunk lean mass … 1.6 0.3 to 3.0 0.020 … 2.4 −2.5 to 7.2 0.338
Peripheral lean mass … 1.8 0.2 to 3.5 0.033 … 5.7 1.0 to 10.4 0.017
Triglycerides … 2.8 −2.6 to 8.2 0.312 … 10.2 −1.3 to 21.7 0.082
Insulin … 9.8 2.1 to 17.6 0.013 … 45.4 29.5 to 61.3 <0.001
Glucose … 0.4 −0.9 to 1.7 0.522 … 3.7 1.3 to 6.1 0.003
CRP … 14.3 −1.4 to 29.9 0.074 … 49.9 20.3 to 79.5 0.001
s% estimates are symmetrical percentage differences. Results estimated using confounder-adjusted regression models applied to multiply imputed data and weighted 
by posterior probabilities of most likely class membership. BMI indicates body mass index; cIMT, carotid intima-media thickness; CRP, C-reactive protein; DBP, diastolic 
blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LVMI, left ventricular mass indexed to height in m3; PWV, pulse 
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classes identified to adulthood cardiometabolic health 
measures. The studies by Hao et al10 and Oluwagbemi-
gun et al11 both had a sample size of only ≈650 individu-
als and discovered uninformative low, middle, and high 
BMI trajectory classes. These studies implemented a 
group-based or latent-class trajectory model, which is a 
heavily constrained type of mixture model that (unrealis-
tically) assumes no individual variation in growth within 
each class. This introduces potential problems of mean-
ing and utility of the derived classes.23 The Buscot et al9 
study of 2631 individuals in the Cardiovascular Risk in 
Young Finns Study presents a stronger analysis but is 
not without limitations. They also identified 6 classes, but 
the average BMI trajectories (between 6 and 49 years) 
were different compared with those presented in the 
present article, at comparable ages. This must at least 
partly be due to the different BMI measurement sched-
ules and age ranges. The authors reported that trajecto-
ries of worsening or persistent obesity were associated 
with increased risk of outcomes including type 2 diabe-
tes and hypertension, but these estimates were based on 
small numbers (eg, 7 individuals had type 2 diabetes in 
the persistent increasing overweight/obese class).
Over half of our sample demonstrated 1 of the 2 tra-
jectories that persisted in the normal-weight BMI cate-
gory. Individuals in these normal-weight trajectory classes 
subsequently displayed, on average, the most optimal 
cardiometabolic profiles in young adulthood, thus provid-
ing further evidence of the benefits associated with the 
management of a healthy weight in childhood and ado-
lescence. Approximately 6% of our sample belonged to 
a class with an average trajectory that started in the nor-
mal-weight range at 7.5 years but finished in the obesity 
range at 24.5 years. This class had the highest carotid 
intima-media thickness, a subclinical marker of athero-
sclerosis and a surrogate end point for coronary artery 
disease,24 the highest left ventricular mass indexed to 
height in m3, a risk factor for coronary heart disease and 
heart failure,25,26 and the highest E/e′ ratio, a correlate of 
left ventricular diastolic filling pressure that is related to 
cardiac events.27 This class also had 50% higher CRP—
an inflammatory marker related to risk of coronary heart 
disease, stroke, and vascular mortality28—than the class 
whose average BMI trajectory both started and finished 
in the obesity range. These differences clearly demon-
strate the adverse consequences of rapid adolescent 
BMI gain. They are also in agreement with a population-
based cohort study in Sweden, which reported (relevant 
to a normal weight group) a higher hazard ratio for cardio-
vascular mortality in boys who became overweight during 
puberty (hazard ratio, 2.39) than in boys who were consis-
tently overweight (hazard ratio, 1.85).29 The reasons why 
individuals who become obese during adolescence have 
worse cardiometabolic health prospects than individuals 
who have been obese for longer since childhood are not 
well understood. One explanation, supported by work by 
Sachdev et al,30 is that adolescent BMI gains are more 
strongly related (than childhood BMI gains) to increases 
in visceral adiposity.30,31 This was observed here, with the 
normal weight increasing to obesity class having 28% 
more trunk fat than the overweight or obesity class. 
Thereafter, it is well known that centrally stored adipose 
tissue is associated with increases in blood pressure, 
low-grade inflammation, insulin resistance, and impaired 
glucose tolerance.31,32 Alternatively, this may also reflect 
a greater adulthood lean mass in those who had a high 
and stable BMI in childhood compared with those who 
did not become obese until late adolescence, as it has 
been shown that before adolescence, increases in BMI 
are driven primarily by increases in fat-free mass.33
By modeling height growth curves for each class, we 
found that the most deleterious classes tended to be 
taller than their peers initially but transitioned to being 
shorter than their peers in adulthood, due to an earlier 
and lower magnitude of peak height velocity. This pattern 
of growth has been documented before in children with 
obesity,34 and both earlier puberty and shorter adulthood 
height are related to increased risk of cardiometabolic 
disease–related morbidity and mortality.35,36 Relevant 
to the archetypical normal-weight group, the childhood 
height advantage was the least pronounced and the 
final height deficit was the most pronounced, in the two 
classes with average BMI trajectories that demonstrated 
rapid gain. This suggests that it might be rapid BMI gain 
rather than obesity per se which results in earlier puberty 
and shorter adulthood height.
The ALSPAC cohort is predominantly White Brit-
ish, with low levels of socioeconomic deprivation, which 
may limit generalizability of the findings. Approximately 
25% of the initial ALSPAC cohort participated in the 
24-year clinic sweep, and differential selection into our 
sample may have biased results.37 A pragmatic decision 
was made to analyze data from both sexes together, as 
was done by Buscot et al9 and others.19 While there are 
systematic differences in childhood BMI between boys 
and girls, this is not a reason to hypothesize that there 
should be a different number of latent classes for each 
sex. Further, stratifying analyses by sex would have led to 
smaller classes and reduced the power of our regression 
models investigating relationship with cardiometabolic 
outcomes. However, as sensitivity analyses, we refitted 
our final growth mixture model as a multigroup mode 
to investigate whether, in each trajectory class, growth 
parameters differed between the sexes. We did not find 
strong evidence to suggest that trajectories differed 
between the sexes. We also ran sex-specific regression 
models to investigate whether the relationship between 
the trajectory classes and cardiometabolic health mea-
sures differed by sex, and we observed similar patterns 
of results to those observed with sexes combined. In this 
second step of the analysis, we did not adjust for BMI 
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the estimates due to conditioning on a mediator. The 
carotid intima-media thickness, pulse wave velocity, and 
echocardiogram outcomes had large amounts of missing 
data, but results were comparable in the main analysis 
(which accounted for missing data using multiple imputa-
tion) and in a sensitivity analysis in which the outcomes 
were not imputed.
In conclusion, this article demonstrates how the rela-
tionship of young-adulthood overweight or obesity with 
cardiometabolic health is dependent on the process by 
which a child becomes overweight or obese. Individuals 
who have high and stable BMI across childhood may 
have lower cardiometabolic disease risk than individu-
als who do not become overweight or obese until late 
adolescence. At a time when the focus of obesity and 
related-disease prevention is increasingly targeting early 
childhood, this is an important consideration for research-
ers, clinicians, and public health officials.
ARTICLE INFORMATION
Received December 9, 2020; accepted February 12, 2021.
Affiliations
School of Sport, Exercise and Health Sciences, Loughborough University, United 
Kingdom (T.N., E.O., W.J.). Centre for Global Child Health, The Hospital for Sick Chil-
dren, Toronto, Canada (L.M.). Leeds Institute for Data Analytics (M.S.G.) and Faculty 
of Medicine and Health (M.S.G.), University of Leeds, United Kingdom. Alan Tur-
ing Institute, British Library, London, United Kingdom (M.S.G.). Division of Surgery 
and Interventional Sciences, Faculty of Medical Sciences (M.H.), CLOSER (Cohort 
and Longitudinal Studies Enhancement Resources), Department of Social Science 
(R.H.), Institute of Cardiovascular Science (A.D.H.), Population, Policy and Practice 
Programme, Great Ormond Street Institute of Child Health (L.L., R.M.V.), and De-
partment of Social Science, Centre for Longitudinal Studies (G.B.P., R.J.S.), Univer-
sity College London, United Kingdom. MRC (Medical Research Council) Integrative 
Epidemiology Unit at the University of Bristol, Department of Population Health 
Sciences, University of Bristol, United Kingdom (L.D.H.). MRC Epidemiology Unit 
and Department of Paediatrics, University of Cambridge, United Kingdom (K.K.O.).
Acknowledgments
We are extremely grateful to all the families who took part in this study, the 
midwives for their help in recruiting them, and the whole ALSPAC team, which 
includes interviewers, computer and laboratory technicians, clerical workers, re-
search scientists, volunteers, managers, receptionists, and nurses.
Sources of Funding
This work was funded by the UK Medical Research Council (WJ New In-
vestigator Research Grant: MR/P023347/1). The British Heart Foundation 
(CS/15/6/31468) funded the collection of cardiovascular data at age 24 years. 
W. Johnson acknowledges support from the National Institute for Health Research 
(NIHR) Leicester Biomedical Research Centre, which is a partnership between the 
University Hospitals of Leicester NHS Trust, Loughborough University, and the Uni-
versity of Leicester. L. Mansukoski is supported by the SickKids, Centre for Global 
Child Health, Child Growth and Development Fellowship. R. Hardy is the direc-
tor of the CLOSER (Cohort and Longitudinal Studies Enhancement Resources) 
consortium, which is funded by the Economic and Social Research Council (ES/
K000357/1). L.D. Howe is funded by a Career Development Award from the UK 
Medical Research Council MR/M020894/1 and works in a unit that receives 
funding from the University of Bristol and the UK Medical Research Council (MC_
UU_12013/6). The UK Medical Research Council and Wellcome Trust (grant ref: 
102215/2/13/2) and the University of Bristol provide core support for ALSPAC. 
This publication is the work of the authors, and W. Johnson will serve as guarantor 
for the contents of this article. A comprehensive list of grant funding is available on 
the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-
acknowledgements.pdf); this research was funded by the British Heart Foundation 
(grant ref: CS/15/6/31468), Wellcome Trust and UK Medical Research Council 




 1. NCD Risk Factor Collaboration. Worldwide trends in body-mass index, 
underweight, overweight, and obesity from 1975 to 2016: a pooled analysis 
of 2416 population-based measurement studies in 128.9 million children, 
adolescents, and adults. Lancet. 2017;390:2627–2642.
 2. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, 
Mokdad AH, Moradi-Lakeh M, Naghavi M, et al; GBD 2015 Obesity Col-
laborators. Health effects of overweight and obesity in 195 countries over 
25 years. N Engl J Med. 2017;377:13–27. doi: 10.1056/NEJMoa1614362
 3. Johnson W. Body size trajectories and cardio-metabolic resilience to obesity. 
Nutr Bull. 2018;43:456–462. doi: 10.1111/nbu.12350
 4. Abraham S, Collins G, Nordsieck M. Relationship of childhood weight status 
to morbidity in adults. HSMHA Health Rep. 1971;86:273–284.
 5. Bjerregaard LG, Jensen BW, Ängquist L, Osler M, Sørensen TIA, Baker JL. 
Change in overweight from childhood to early adulthood and risk of 
type 2 diabetes. N Engl J Med. 2018;378:1302–1312. doi: 10.1056/ 
NEJMoa1713231
 6. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, 
Srinivasan SR, Daniels SR, Davis PH, Chen W, et al. Childhood adiposity, adult 
adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365:1876–
1885. doi: 10.1056/NEJMoa1010112
 7. Nedelec R, Jokelainen J, Miettunen J, Ruokonen A, Herzig KH, Männikkö M, 
Järvelin MR, Sebert S. Early determinants of metabolically healthy obesity in 
young adults: study of the Northern Finland Birth Cohort 1966. Int J Obes 
(Lond). 2018;42:1704–1714. doi: 10.1038/s41366-018-0115-0
 8. Smith KJ, Magnussen CG, Pahkala K, Koskinen J, Sabin MA, Hutri-Kähönen 
N, Kähönen M, Laitinen T, Tammelin T, Tossavainen P, et al. Youth to adult 
body mass index trajectories as a predictor of metabolically healthy obe-
sity in adulthood. Eur J Public Health. 2020;30:195–199. doi: 10.1093/ 
eurpub/ckz109
 9. Buscot MJ, Thomson RJ, Juonala M, Sabin MA, Burgner DP, Lehtimäki T, 
Hutri-Kähönen N, Viikari JSA, Raitakari OT, Magnussen CG. Distinct child-
to-adult body mass index trajectories are associated with different lev-
els of adult cardiometabolic risk. Eur Heart J. 2018;39:2263–2270. doi: 
10.1093/eurheartj/ehy161
 10. Hao G, Wang X, Treiber FA, Harshfield G, Kapuku G, Su S. Body mass index 
trajectories in childhood is predictive of cardiovascular risk: results from the 
23-year longitudinal Georgia Stress and Heart study. Int J Obes (Lond). 
2018;42:923–925. doi: 10.1038/ijo.2017.244
 11. Oluwagbemigun K, Buyken AE, Alexy U, Schmid M, Herder C, Nöthlings  
U. Developmental trajectories of body mass index from childhood into late 
adolescence and subsequent late adolescence-young adulthood cardio-
metabolic risk markers. Cardiovasc Diabetol. 2019;18:9. doi: 10.1186/ 
s12933-019-0813-5
 12. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, Molloy L, 
Ness A, Ring S, Davey Smith G. Cohort profile: the ‘children of the 90s’–the 
index offspring of the Avon Longitudinal Study of Parents and Children. Int 
J Epidemiol. 2013;42:111–127. doi: 10.1093/ije/dys064
 13. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, 
Henderson J, Macleod J, Molloy L, Ness A, et al. Cohort profile: the Avon 
Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J 
Epidemiol. 2013;42:97–110. doi: 10.1093/ije/dys066
 14. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, 
Delacqua G, Delacqua F, Kirby J, et al; REDCap Consortium. The REDCap 
consortium: building an international community of software platform part-
ners. J Biomed Inform. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208
 15. Vanoli D, Wiklund U, Lindqvist P, Henein M, Näslund U. Successful novice’s 
training in obtaining accurate assessment of carotid IMT using an auto-
mated ultrasound system. Eur Heart J Cardiovasc Imaging. 2014;15:637–
642. doi: 10.1093/ehjci/jet254
 16. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF III, Dokainish H, Edvardsen T, 
Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, et al. Recommenda-
tions for the evaluation of left ventricular diastolic function by echocardiog-
raphy: an update from the American Society of Echocardiography and the 
European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 
2016;29:277–314. doi: 10.1016/j.echo.2016.01.011
 17. Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs 





 http://ahajournals.org by on A
pril 16, 2021
CLINICAL AND POPULATION 
STUDIES - VB
Norris et al BMI Classes and Cardiometabolic Health
Arterioscler Thromb Vasc Biol. 2021;41:1580–1593. DOI: 10.1161/ATVBAHA.120.315782 April 2021  1593
 18. Cole TJ, Donaldson MD, Ben-Shlomo Y. SITAR–a useful instrument 
for growth curve analysis. Int J Epidemiol. 2010;39:1558–1566. doi: 
10.1093/ije/dyq115
 19. Mattsson M, Maher GM, Boland F, Fitzgerald AP, Murray DM, 
Biesma R. Group-based trajectory modelling for BMI trajectories in 
childhood: a systematic review. Obes Rev. 2019;20:998–1015. doi: 
10.1111/obr.12842
 20. Barraclough JY, Garden FL, Toelle BG, Marks GB, Baur LA, Ayer JG, 
Celermajer DS. Weight gain trajectories from birth to adolescence and car-
diometabolic status in adolescence. J Pediatr. 2019;208:89–95.e4. doi: 
10.1016/j.jpeds.2018.12.034
 21. Fan B, Yang Y, Dayimu A, Zhou G, Liu Y, Li S, Chen W, Zhang T, Xue F. 
Body mass index trajectories during young adulthood and incident hyper-
tension: a Longitudinal Cohort in Chinese Population. J Am Heart Assoc. 
2019;8:e011937. doi: 10.1161/JAHA.119.011937
 22. Péneau S, Giudici KV, Gusto G, Goxe D, Lantieri O, Hercberg S, 
Rolland-Cachera MF. Growth trajectories of body mass index during child-
hood: associated factors and health outcome at adulthood. J Pediatr. 
2017;186:64–71.e1. doi: 10.1016/j.jpeds.2017.02.010
 23. Gilthorpe MS, Dahly DL, Tu YK, Kubzansky LD, Goodman E. Challenges in 
modelling the random structure correctly in growth mixture models and the 
impact this has on model mixtures. J Dev Orig Health Dis. 2014;5:197–205. 
doi: 10.1017/S2040174414000130
 24. O’Leary DH, Polak JF. Intima-media thickness: a tool for atherosclero-
sis imaging and event prediction. Am J Cardiol. 2002;90:18L–21L. doi: 
10.1016/s0002-9149(02)02957-0
 25. de Simone G, Gottdiener JS, Chinali M, Maurer MS. Left ventricular 
mass predicts heart failure not related to previous myocardial infarction: 
the Cardiovascular Health Study. Eur Heart J. 2008;29:741–747. doi: 
10.1093/eurheartj/ehm605
 26. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricu-
lar mass and incidence of coronary heart disease in an elderly cohort. 
The Framingham Heart Study. Ann Intern Med. 1989;110:101–107. doi: 
10.7326/0003-4819-110-2-101
 27. Sharp AS, Tapp RJ, Thom SA, Francis DP, Hughes AD, Stanton AV, 
Zambanini A, O’Brien E, Chaturvedi N, Lyons S, et al; ASCOT Investiga-
tors. Tissue Doppler E/E’ ratio is a powerful predictor of primary cardiac 
events in a hypertensive population: an ASCOT substudy. Eur Heart J. 
2010;31:747–752. doi: 10.1093/eurheartj/ehp498
 28. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, 
Danesh J; Emerging Risk Factors Collaboration. C-reactive protein con-
centration and risk of coronary heart disease, stroke, and mortality: an 
individual participant meta-analysis. Lancet. 2010;375:132–140. doi: 
10.1016/S0140-6736(09)61717-7
 29. Ohlsson C, Bygdell M, Sondén A, Rosengren A, Kindblom JM. Association 
between excessive BMI increase during puberty and risk of cardiovascu-
lar mortality in adult men: a population-based cohort study. Lancet Diabetes 
Endocrinol. 2016;4:1017–1024. doi: 10.1016/S2213-8587(16)30273-X
 30. Sachdev HS, Fall CH, Osmond C, Lakshmy R, Dey Biswas SK, Leary SD, 
Reddy KS, Barker DJ, Bhargava SK. Anthropometric indicators of body 
composition in young adults: relation to size at birth and serial measure-
ments of body mass index in childhood in the New Delhi birth cohort. Am J 
Clin Nutr. 2005;82:456–466. doi: 10.1093/ajcn.82.2.456
 31. Kindblom JM, Lorentzon M, Hellqvist A, Lönn L, Brandberg J, Nilsson S, 
Norjavaara E, Ohlsson C. BMI changes during childhood and adolescence 
as predictors of amount of adult subcutaneous and visceral adipose tis-
sue in men: the GOOD Study. Diabetes. 2009;58:867–874. doi: 10.2337/ 
db08-0606
 32. Bhargava SK, Sachdev HS, Fall CH, Osmond C, Lakshmy R, Barker DJ, 
Biswas SK, Ramji S, Prabhakaran D, Reddy KS. Relation of serial changes 
in childhood body-mass index to impaired glucose tolerance in young adult-
hood. N Engl J Med. 2004;350:865–875. doi: 10.1056/NEJMoa035698
 33. Maynard LM, Wisemandle W, Roche AF, Chumlea WC, Guo SS, Siervogel RM. 
Childhood body composition in relation to body mass index. Pediatrics. 
2001;107:344–350. doi: 10.1542/peds.107.2.344
 34. Metcalf BS, Hosking J, Frémeaux AE, Jeffery AN, Voss LD, Wilkin TJ. BMI 
was right all along: taller children really are fatter (implications of making 
childhood BMI independent of height) EarlyBird 48. Int J Obes (Lond). 
2011;35:541–547. doi: 10.1038/ijo.2010.258
 35. Day FR, Elks CE, Murray A, Ong KK, Perry JR. Puberty timing associated 
with diabetes, cardiovascular disease and also diverse health outcomes 
in men and women: the UK Biobank study. Sci Rep. 2015;5:11208. doi: 
10.1038/srep11208
 36. Emerging Risk Factors Collaboration. Adult height and the risk of cause-specific 
death and vascular morbidity in 1 million people: individual participant meta-
analysis. Int J Epidemiol. 2012;41:1419–1433. doi: 10.1093/ije/dys086
 37. Munafò MR, Tilling K, Taylor AE, Evans DM, Davey Smith G. Collider scope: 
when selection bias can substantially influence observed associations. Int J 




 http://ahajournals.org by on A
pril 16, 2021
